<PAGE> 1
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
OCTOBER 4, 2000
Date of Report (date of earliest event reported)
AURORA BIOSCIENCES CORPORATION
(Exact name of Registrant as specified in charter)
<TABLE>
<S> <C> <C>
DELAWARE 0-22669 33-0669859
--------------------------------- ---------------------------- -----------------------------
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)
</TABLE>
11010 N. TORREYANA ROAD
SAN DIEGO, CALIFORNIA 92121
(Address of principal executive offices)
Registrant's telephone number, including area code: (858) 404-6600
N/A
(Former name or former address, if changed since last report)
================================================================================
<PAGE> 2
ITEM 2. OTHER EVENTS.
On October 20, 2000, Aurora Biosciences Corporation, a Delaware
corporation ("Aurora"), issued a press release announcing its acquisition of
Quorum Sciences, Inc. The acquisition was completed on October 4, 2000. A copy
of the press release is attached as Exhibit 99.1 hereto and incorporated herein
by this reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) 99.1 Press Release issued on October 20, 2000 by Aurora.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
AURORA BIOSCIENCES CORPORATION
By: /s/ Stuart J.M. Collinson
-------------------------------------
Stuart J.M. Collinson,
Chief Executive Officer and President
Date: November 2, 2000
<PAGE> 4
INDEX TO EXHIBITS
99.1. Press Release issued on October 20, 2000 by Aurora Biosciences
Corporation
